Marthi Pretorius

Marthi Pretorius

Auto-generated profile, based on publicly available information

Marthi Pretorius

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2014 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
NWNicole Wolter
Nicole Wolter
STStefano Tempia
Stefano Tempia
CCCheryl Cohen
Cheryl Cohen
SMShabir A. Madhi
Shabir A. Madhi
MVMarietjie Venter
Marietjie Venter
AGAnne von Gottberg
Anne von Gottberg
Background. We identified factors associated with pneumococcal colonization, high colonization density, and invasive pneumococcal pneumonia among patients hospitalized with acute lower respiratory tract infections (ALRTIs). Methods. In 2010, 4025 cases were enrolled in surveillance in South Africa. A total of 969 of 4025 systematically selected nasopharyngeal-oropharyngeal specimens (24%) were tested for respiratory viruses and Streptococcus pneumoniae by real-time polymerase chain reaction. Of these, 749 (77%) had blood tested for S. pneumoniae. Results. Pneumococcal colonization was detected in 55% of cases (534 of 969). On multivariable analysis that controlled for age and tuberculosis treatment, infection with influenza virus (adjusted odds ratio [OR], 2.2; 95% confidence interval [CI], 1.1–4.5), adenovirus (adjusted OR, 1.7; 95% CI, 1.1–2.7), rhinovirus (adjusted OR, 1.6; 95% CI, 1.1–2.3), and human immunodeficiency virus (HIV; adjusted OR, 1.6; 95% CI, 1.1–2.4) were associated with pneumococcal colonization. High colonization density was associated with respiratory virus coinfection (adjusted OR, 1.7; 95% CI, 1.1–2.6) and invasive pneumococcal pneumonia (adjusted OR, 2.3; 95% CI, 1.3–4.0), after adjustment for age and sex. Seven percent (52 of 749) had pneumococci detected in blood. On multivariable analysis among colonized cases, invasive pneumococcal pneumonia was associated with HIV (adjusted OR, 3.2; 95% CI, 1.4–7.5), influenza virus (adjusted OR, 8.2; 95% CI, 2.7–25.0), high colonization density (adjusted OR, 18.7; 95% CI, 2.3–155.1), and ≥5 days of hospitalization (adjusted OR, 3.7; 95% CI, 1.7–8.2). Conclusions. Respiratory virus infection was associated with elevated colonization density and, in turn, invasive pneumococcal pneumonia.

1 November 2013 in Emerging Infectious Diseases
Verified
Journal Article
Open access
CCCheryl Cohen
Cheryl Cohen
JMJocelyn Moyes
Jocelyn Moyes
STStefano Tempia
Stefano Tempia
MGMichelle Groom
Michelle Groom
SWSibongile Walaza
Sibongile Walaza
SMShabir A. Madhi
Shabir A. Madhi
Data on influenza epidemiology in HIV-infected persons are limited, particularly for sub-Saharan Africa, where HIV infection is widespread. We tested respiratory and blood samples from patients with acute lower respiratory tract infections hospitalized in South Africa during 2009–2011 for viral and pneumococcal infections. Influenza was identified in 9% (1,056/11,925) of patients enrolled; among influenza case-patients, 358 (44%) of the 819 who were tested were infected with HIV. Influenza-associated acute lower respiratory tract infection incidence was 4–8 times greater for HIV-infected (186–228/100,000) than for HIV-uninfected persons (26–54/100,000). Furthermore, multivariable analysis showed HIV-infected patients were more likely to have pneumococcal co-infection; to be infected with influenza type B compared with type A; to be hospitalized for 2–7 days or >7 days; and to die from their illness. These findings indicate that HIV-infected persons are at greater risk for severe illnesses related to influenza and thus should be prioritized for influenza vaccination.

15 December 2012 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MPMarthi A Pretorius
Marthi A Pretorius
SMShabir A. Madhi
Shabir A. Madhi
CCCheryl Cohen
Cheryl Cohen
DNDhamari Naidoo
Dhamari Naidoo
MGMichelle Groome
Michelle Groome
MVMarietjie Venter
Marietjie Venter
Background. Data about respiratory coinfections with 2009 pandemic influenza A virus subtype H1N1 during the 2009–2010 influenza pandemic in Africa are limited. We used an existing surveillance program for severe acute respiratory illness to evaluate a new multiplex real-time polymerase chain reaction assay and investigate the role of influenza virus and other respiratory viruses in pneumonia hospitalizations during and after the influenza pandemic in South Africa. Methods. The multiplex assay was developed to detect 10 respiratory viruses, including influenza A and B viruses, parainfluenza virus types 1–3, respiratory syncytial virus (RSV), enterovirus, human metapneumovirus (hMPV), adenovirus (AdV), and rhinovirus (RV), followed by influenza virus subtyping. Nasopharyngeal and oropharyngeal specimens were collected from patients hospitalized with pneumonia at 6 hospitals during 2009–2010. Results. Validation against external quality controls confirmed the high sensitivity (91%) and specificity (100%) and user-friendliness, compared with other PCR technologies. Of 8173 patients, 40% had single-virus infections, 17% had coinfections, and 43% remained negative. The most common viruses were RV (25%), RSV (14%), AdV (13%), and influenza A virus (5%). Influenza virus, RSV, PIV type 3, and hMPV showed seasonal patterns. Conclusion. The data provide a better understanding of the viral etiology of hospitalized cases of pneumonia and demonstrate the usefulness of this multiplex assay in respiratory disease surveillance in South Africa.

21 November 2013 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
AHAmber K. Haynes
Amber K. Haynes
AMArie P. Manangan
Arie P. Manangan
MIMarika K. Iwane
Marika K. Iwane
KSKatharine Sturm-Ramirez
Katharine Sturm-Ramirez
NHNusrat Homaira
Nusrat Homaira
SGSusan I. Gerber
Susan I. Gerber
Background. Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children globally, with the highest burden in low- and middle-income countries where the association between RSV activity and climate remains unclear. Methods. Monthly laboratory-confirmed RSV cases and associations with climate data were assessed for respiratory surveillance sites in tropical and subtropical areas (Bangladesh, China, Egypt, Guatemala, Kenya, South Africa, and Thailand) during 2004–2012. Average monthly minimum and maximum temperatures, relative humidity, and precipitation were calculated using daily local weather data from the US National Climatic Data Center. Results. RSV circulated with 1–2 epidemic periods each year in site areas. RSV seasonal timing and duration were generally consistent within country from year to year. Associations between RSV and weather varied across years and geographic locations. RSV usually peaked in climates with high annual precipitation (Bangladesh, Guatemala, and Thailand) during wet months, whereas RSV peaked during cooler months in moderately hot (China) and arid (Egypt) regions. In South Africa, RSV peaked in autumn, whereas no associations with seasonal weather trends were observed in Kenya. Conclusions. Further understanding of RSV seasonality in developing countries and various climate regions will be important to better understand the epidemiology of RSV and for timing the use of future RSV vaccines and immunoprophylaxis in low- and middle-income countries.

29 March 2016 in Pediatrics
Verified
Journal Article
Closed access
PDF file
CCCheryl Cohen
Cheryl Cohen
JMJocelyn Moyes
Jocelyn Moyes
STStefano Tempia
Stefano Tempia
MGMichelle Groome
Michelle Groome
SWSibongile Walaza
Sibongile Walaza
SMShabir A. Madhi
Shabir A. Madhi
BACKGROUND: Increased morbidity and mortality from lower respiratory tract infection (LRTI) has been suggested in HIV-exposed uninfected (HEU) children; however, the contribution of respiratory viruses is unclear. We studied the epidemiology of LRTI hospitalization in HIV-unexposed uninfected (HUU) and HEU infants aged <6 months in South Africa. METHODS: We prospectively enrolled hospitalized infants with LRTI from 4 provinces from 2010 to 2013. Using polymerase chain reaction, nasopharyngeal aspirates were tested for 10 viruses and blood for pneumococcal DNA. Incidence for 2010–2011 was estimated at 1 site with population denominators. RESULTS: We enrolled 3537 children aged <6 months. HIV infection and exposure status were determined for 2507 (71%), of whom 211 (8%) were HIV infected, 850 (34%) were HEU, and 1446 (58%) were HUU. The annual incidence of LRTI was elevated in HEU (incidence rate ratio [IRR] 1.4; 95% confidence interval [CI] 1.3–1.5) and HIV infected (IRR 3.8; 95% CI 3.3–4.5), compared with HUU infants. Relative incidence estimates were greater in HEU than HUU, for respiratory syncytial virus (RSV; IRR 1.4; 95% CI 1.3–1.6) and human metapneumovirus–associated (IRR 1.4; 95% CI 1.1–2.0) LRTI, with a similar trend observed for influenza (IRR 1.2; 95% CI 0.8–1.8). HEU infants overall, and those with RSV-associated LRTI had greater odds (odds ratio 2.1, 95% CI 1.1–3.8, and 12.2, 95% CI 1.7–infinity, respectively) of death than HUU. CONCLUSIONS: HEU infants were more likely to be hospitalized and to die in-hospital than HUU, including specifically due to RSV. This group should be considered a high-risk group for LRTI.

21 November 2013 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JMJocelyn Moyes
Jocelyn Moyes
CCCheryl Cohen
Cheryl Cohen
MPMarthi Pretorius
Marthi Pretorius
MGMichelle Groome
Michelle Groome
AGAnne von Gottberg
Anne von Gottberg
FGfor the South African Severe Acute Respiratory Illness Surveillance Group
for the South African Severe Acute Respiratory Illness Surveillance Group
Background. There are limited data on respiratory syncytial virus (RSV) infection among children in settings with a high prevalence of human immunodeficiency virus (HIV). We studied the epidemiology of RSV-associated acute lower respiratory tract infection (ALRTI) hospitalizations among HIV-infected and HIV-uninfected children in South Africa. Methods. Children aged 5 days (adjusted odds ratio, 4.0; 95% CI, 1.5–10.6) than HIV-uninfected children. Conclusion. HIV-infected children have a higher risk of hospitalization with RSV-associated ALRTI and a poorer outcome than HIV-uninfected children. These children should be targeted for interventions aimed at preventing severe RSV disease.